Evidence map›Paper›PMID 38323101›Full record

ArticleJPRAS open2024

Oculopalpebral prosthesis prototype design using the additive manufacturing technique: A case study.

E Vázquez-Silva, D D Bohorquez-Vivas, P G Peña-Tapia, F P Moncayo-Matute, P B Torres-Jara, D P Moya-Loaiza

Abstract read
In one paragraph

Article in JPRAS open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

E Vázquez-SilvaDepartment of Mechanical Engineering/Research Group on New Materials and Transformation Processes (GIMAT), Salesian Polytechnic University (UPS), Cuenca, Azuay, Ecuador.
D D Bohorquez-VivasDepartment of Mechanical Engineering/Research Group on New Materials and Transformation Processes (GIMAT), Salesian Polytechnic University (UPS), Cuenca, Azuay, Ecuador.
P G Peña-TapiaDepartment of Neurosurgery/Society for the Fight Against Cancer, SOLCA Cancer Institute, Cuenca, Azuay, Ecuador.
F P Moncayo-MatuteDepartment of Mechanical Engineering/Research Group on New Materials and Transformation Processes (GIMAT), Salesian Polytechnic University (UPS), Cuenca, Azuay, Ecuador.
P B Torres-JaraDepartment of Mechanical Engineering/Research Group on New Materials and Transformation Processes (GIMAT), Salesian Polytechnic University (UPS), Cuenca, Azuay, Ecuador.
D P Moya-LoaizaDepartment of Mechanical Engineering/Research Group on New Materials and Transformation Processes (GIMAT), Salesian Polytechnic University (UPS), Cuenca, Azuay, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three-dimensional (3D) printing technology has advanced for applications in the field of reconstructive surgery. This study reports the application of a comprehensive methodology to obtain an anatomical model, using computed tomography and 3D printing, to treat a patient with cancer who designed a prototype oculopalpebral prosthesis for the reconstruction of the affected area of the face (left eye). A personalized prototype was obtained, which adapted to the face of the person, and improved the aesthetics and quality of life. The applied techniques helped to make definitive prostheses using materials that could be permanent. The training and tests carried out in this study favored the understanding and assimilation of the technology and the possibility of applying it to patients in need of facial prosthetic rehabilitation.

Indexed as

3D printingAblative oncology surgeryAnaplastologyComputerized tomographyOculopalpebralStereolithography

Identifiers

PMID38323101
PMCPMC10843991

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.